Bruker takes majority stake in organ-on-a-chip developer MIMETAS

Reuters2026/08/11 05:54

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Bruker took a majority stake in Dutch organ-on-a-chip developer MIMETAS.
The deal pairs MIMETAS’ tissue-model platforms with Bruker’s proteomics, metabolomics, imaging, and molecular analysis tools.
MIMETAS will continue to operate under its own name with its existing management team.
Ontwikkelingsmaatschappij Oost-Nederland NV, an early investor, said proceeds will be redeployed into new innovative startups.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ontwikkelingsmaatschappij Oost-Nederland NV published the original content used to generate this news brief on August 11, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Bruker takes majority stake in organ-on-a-chip developer MIMETAS

You may also like

Crypto prices